Lung Cancer

Health Condition

Lung Cancer Prevention

Healthy Lifestyle Tips

The following lifestyle changes have been studied in connection with lung cancer.

Smoking

Cigarette smoking is universally acknowledged to be the leading cause of lung cancer, both in the United States and worldwide. By far the most important way to reduce the risk of lung cancer is to not smoke.66

Passive smoke

Many studies now show that exposure to passive smoke—the cigarette smoke from others’ cigarettes—significantly increases the risk of lung cancer.67 As non-smoking sections of restaurants have nearly the same level of smoke as do the smoking sections, it makes sense to seek restaurants that do not permit any smoking and to avoid bars unless they are also non-smoking establishments.

Other inhalant pollution

Inhalant exposure to diesel exhaust, pitch and tar, dioxin, arsenic, chromium, cadmium, and nickel compounds may also increase the risk of lung cancer.66 Exposure to asbestos is associated with an increased risk of lung cancer.

Radon exposure has been reported to contribute to the risk of lung cancer in the general population.69 Radon, a natural radioactive substance, can leak into basements from the surrounding soil. Radon exposure can also occur from the water system of houses, particularly when people take showers. Underground miners are also exposed to varying amounts of radioactivity from radon.

References

1. Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 1996;88:1550-9.

2. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.

3. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-9.

4. Doering W von E. Antioxidant vitamins, cancer and cardiovascular disease. N Engl J Med 1996;335:1065 [letter].

5. Ben-Amotz A, Levy Y. Bioavailability of a natural isomer mixture compared with synthetic all-transß-carotene in human serum. Am J Clin Nutr 1996;63:729-34.

6. Yeum KJ, Azhu S, Xiao S, et al. Beta-carotene intervention trial in premalignant gastric lesions. J Am Coll Nutr 1995;14:536 [abstr #48].

7. Johnson EJ, Krinsky NI, Russell RM. Serum response of all-trans and 9-cis isomers of ß-carotene in humans. J Am Coll Nutr1996;15:620-4.

8. Shekelle RB, Lepper M, Liu S, et al. Dietary vitamin A and risk of cancer in the Western Electric Study. Lancet 1981;2:1185-90.

9. Medina D. Mechanisms of selenium inhibition of tumorigenesis. Adv Exp Med Biol 1986;206:465-72.

10. Beisel WR. Single nutrients and immunity. Am J Clin Nutr 1982;35:417-68.

11. Medina D, Morrison DG. Current ideas on selenium as a chemopreventative agent. Pathol Immunopathol Res 1988;7:187-99.

12. Shamberger RJ, Rukoven E, Lonfield AK, et al. Antioxidants and cancer. I. Selenium in the blood of normals and cancer patients. J Natl Cancer Inst 1973;4:863-70.

13. Burney PGJ, Comstock GW, Morris JS. Serologic precursors of cancer: serum micronutrients and the subsequent risk of pancreatic cancer. Am J Clin Nutr 1989;49:895-900.

14. Toma S, Micheletti A, Giacchero A, et al. Selenium therapy in patients with precancerous and malignant oral cavity lesions: preliminary results. Cancer Detection Prev 1991;15:491-3.

15. Willett WC, Polk BF, Morris JS, et al. Prediagnostic serum Selenium and risk of cancer. Lancet 1983;42:130-4.

16. Helzlsouer KJ, Comstock GW, Morris JS. Selenium, lycopene, alpha-tocopherol, ß-carotene, retinol, and subsequent bladder cancer. Cancer Res 1989;49:6144-8.

17. Jaskiewicz K, Marasas WF, Rossouw JE, et al. Selenium and other mineral elements in populations at risk for esophageal cancer. Cancer 1988;62:2635-9.

18. Knekt P, Aromaa A, Maatela J, et al. Serum selenium and subsequent risk of cancer among Finnish men and women. J Natl Cancer Inst 1990;82:864-8.

19. Yu M-W, Horng I-S, Hsu K-H, et al. Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic hepatitis virus infection. Am J Epidemiol 1999;150:367-74.

20. Scieszka M, Danch A, Machalski M, Drozdz M. Plasma selenium concentration in patients with stomach and colon cancer in the Upper Silesia. Neoplasma 1997;44:395-7.

21. Knekt P, Marniemi J, Teppo L, et al. Is low selenium status a risk factor for lung cancer? Am J Epidemiol 148:975-82.

22. Fex G, Pettersson B, Akesson B. Low plasma selenium as a risk factor for cancer death in middle-aged men. Nutr Cancer 1987;10:221-9.

23. Salonen J, Salonen R, Lappetelainen R, et al. Risk of cancer in relation to serum concentrations of selenium and vitamins A and E; matched case-control analysis of prospective data. BMJ 1985;290:417-20.

24. Clark LC, Combs GF Jr, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA 1996;276:1957-63.

25. Menkes MS, Comstock GW, Vuilleumier JP, et al. Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer. N Engl J Med 1986;315:1250-4.

26. Eichholzer M, Stahelin HB, Gey F, et al. Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel Study. Int J Cancer 1996;66:145-50.

27. Knekt P. Vitamin E and smoking and the risk of lung cancer. Ann NY Acad Sci 1993;686:280-7; discussion 287-8.

28. Mayne ST, Janerich DT, Greenwald P, et al. Dietary beta carotene and lung cancer risk in U.S. nonsmokers. J Natl Cancer Inst 1994;86:33-8.

29. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.

30. Cesano A, Visonneau S, Scimeca JA, et al. Opposite effects of linoleic acid and conjugated linoleic acid on human prostatic cancer in SCID mice. Anticancer Res 1998;18:1429-34.

31. Thompson H, Zhu Z, Banni S, et al. Morphological and biochemical status of the mammary gland as influenced by conjugated linoleic acid: implication for a reduction in mammary cancer risk. Cancer Res 1997;57:5067-72.

32. Ip C. Review of the effects of trans fatty acids, oleic acid, n-3 polyunsaturated fatty acids, and conjugated linoleic acid on mammary carcinogenesis in animals. Am J Clin Nutr 1997;66(suppl):1523S-29S [review].

33. Parodi PW. Cows' milk fat components as potential anticarcinogenic agents. J Nutr 1997;127:1055-60 [review].

34. Heimburger DC, Alexander B, Birch R, et al. Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. Report of a preliminary randomized, double-blind intervention trial. JAMA 1988;259:1525-30.

35. Kono S, Ikeda M, Tokudome S, Kuratsune M. A case-control study of gastric cancer and diet in northern Kyushu, Japan. Jpn J Cancer Res 1988;79:1067-74.

36. Gao YT, McLaughlin JK, Blot WJ, et al. Reduced risk of esophageal cancer associated with green tea consumption. J Natl Cancer Inst 1994;86:855-8.

37. Ji BT, Chow WH, Hsing AW, et al. Green tea consumption and the risk of pancreatic and colorectal cancers. Int J Cancer 1997;70:255-8.

38. Fujiki H. Two stages of cancer prevention with green tea. J Cancer Res Clin Oncol 1999;125:589-97 [review].

39. Ohno Y, Wakai K, Genka K, et al. Tea consumption and lung cancer risk: A case-control study in Okinawa, Japan. Jpn J Cancer Res 1995;86:1027-34.

40. Goldbohm RA, Hertog MGL, Brants HAM, et al. Consumption of black tea and cancer risk: A prospective cohort study. J Natl Cancer Inst 1996;88:93-100.

41. Heilbrun L, Nomura A, Stemmermann G. Black tea consumption and cancer risk: A prospective study. Br J Cancer 1986;54:677-83.

42. Phillips RL, Snowdon DA. Dietary relationship with fatal colorectal cancer among Seven-Day Adventists. J Natl Cancer Inst 1985;74:307-17.

43. Heimburger DC, Alexander B, Birch R, et al. Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. Report of a preliminary randomized, double-blind intervention trial. JAMA 1988;259:1525-30.

44. Pierce RJ, Kune GA, Kune S, et al. Dietary and alcohol intake, smoking pattern occupational risk, and family history in lung cancer patients: results of a case-control study in males. Nutr Cancer 1989;12:237-48.

45. Rose DP, Connolley JM. Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther 1999;83:217-44.

46. Eichholzer M. Ernahrung und Krebs. Ther Umsch 2000;57:146-51 [review in German].

47. Le Marchand L, Murphy SP, Hankin JH, et al. Intake of flavonoids and lung cancer. J Natl Cancer Inst 2000;92:154-60.

48. Knekt P, Jarvinen R, Seppanen R, et al. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol 1997;146:223-30.

49. Hertog MGL, Kromhout D, Aravanis C, et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study. Arch Intern Med 1995;155:381-6.

50. Sinha R, Kulldorff M, Curtin J, et al. Fried, well-done red meat and risk of lung cancer in women (United States). Cancer Causes Control 1998;9:621-30.

51. Deneco-Pellegrini H, De Stefani E, Ronco A, et al. Meat consumption and risk of lung cancer; a case-control study from Uruguay. Lung Cancer 1996;14:195-205.

52. Mohr DL, Blot WJ, Tousey PM, et al. Southern cooking and lung cancer. Nutr Cancer 1999;35:34-43 [review].

53. Levy J, Bosin E, Feldman B, et al. Lycopene is a more potent inhibitor of human cancer cell proliferation than either a-carotene or ß-carotene. Nutr Cancer 1995;24:257-66.

54. Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J Natl Cancer Inst 1999;91:317-31.

55. De Stefani E, Deneo-Pellegrini H, Mendilaharsu M, et al. Dietary fat and lung cancer: a case-control study in Uruguay. Cancer Causes Control 1997;8:913-21.

56. Hinds MW, Kolonel LN, Hankin JH, Lee J. Dietary cholesterol and lung cancer risk in a multiethnic population in Hawaii. Int J Cancer 1983;32:727-32.

57. Shekelle RB, Rossof AH, Stamler J. Dietary cholesterol and incidence of lung cancer: the Western Electric Study. Am J Epidemiol 1991;134:480-4.

58. Wu Y, Zheng W, Sellers TA, et al. Dietary cholesterol, fat, and lung cancer incidence among older women: the Iowa Women's Health Study (United States). Cancer Causes Control 1994;5:395-400.

59. Wynder EL, Herbert JR, Kabat GC. Association of dietary fat and lung cancer. J Natl Cancer Inst 1987;79:631-7.

60. De Stefani E, Deneo-Pellegrini H, Mendilaharsu M, et al. Dietary fat and lung cancer: a case-control study in Uruguay. Cancer Causes Control 1997;8:913-21.

61. Wu Y, Zheng W, Sellers TA, et al. Dietary cholesterol, fat, and lung cancer incidence among older women: the Iowa Women's Health Study (United States). Cancer Causes Control 1994;5:395-400.

62. Alavanja MCR, Brown CC, Swanson C, Brownson RC. Saturated fat intake and lung cancer risk among nonsmoking women in Missouri. J Natl Cancer Inst 1993;85:1906-16.

63. Alavanja MCR, Swansons C, Brown C, Brownson R. Re: Lung cancer: another consequence of a high-fat diet? J Natl Cancer Inst 1994;86:314 [letter].

64. Veierod MB, Laake P, Thelle DS. Dietary fat intake and risk of lung cancer: a prospective study of 51,452 Norwegian men and women. Eur J Cancer Prev 1997;6:540-9.

65. De Stefani E, Deneo-Pellegrini H, Mendilaharsu M, et al. Dietary sugar and lung cancer: a case-control study in Uruguay. Nutr Cancer 1998;31:132-7.

66. Murphy GP, Lawrence W, Lenhard RE (eds). American Cancer Society Textbook of Clinical Oncology, second edition. Atlanta: American Cancer Society, Inc., 1995, 221 [review].

67. Zhong L, Goldberg MS, Parent ME, Hanley JA. Exposure to environmental tobacco smoke and the risk of lung cancer: a meta-analysis. Lung Cancer 2000;27:3-18.

68. Lubin JR, Boice JD Jr. Lung cancer risk from residential radon: meta-analysis of eight epidemiologic studies. J Natl Cancer Inst 1997;89:49-57.

Copyright © 2024 TraceGains, Inc. All rights reserved.

Learn more about TraceGains, the company.

The information presented by TraceGains is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. Self-treatment is not recommended for life-threatening conditions that require medical treatment under a doctor's care. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires December 2024.

drug Image
Check Pricing on Drugs Commonly Used to Treat lung cancer:

Select drug name to view medication information and pricing.

Log In

You need to log into the site to use this feature

Create A Free Account To Use Medicine Chest

This feature requires registration. Sign up or log in to your free WellRx account to gain access to this and other tools to help make managing your medications and wellness easier.

Benefits Include:

Store & manage your medication list
Medication pricing updates
Import medication from your pharmacy
Medication information
Pill & refill reminders
Medication journal & mood log

Sign up to use Medicine Chest

Create A Free Account To Use this feature

This feature requires registration. Sign up or log in to your free WellRx account to gain access to this and other tools to help make managing your medications and wellness easier.

Benefits Include:

Store & manage your medication list
Medication pricing updates
Import medication from your pharmacy
Medication information
Pill & refill reminders
Medication journal & mood log

Sign up to use this feature

You will be redirected to your program in 5 seconds.

Hi there.

Our Terms and Conditions and Privacy Policy have recently been updated.

Learn More


I Accept

By declining you will be logged out of your account

;